Immunology Pipeline
Autoimmune/Inflammatory Diseases
Exploratory/Pre-clinicalActive
Key Facts
Indication
Autoimmune/Inflammatory Diseases
Phase
Exploratory/Pre-clinical
Status
Active
Company
About Centrexion Therapeutics
Centrexion Therapeutics is a clinical-stage biotech targeting two high-value, high-unmet-need sectors: non-opioid chronic pain and immunology. The company leverages deep expertise in pain pathophysiology and autoimmune drug development to build a diversified pipeline of novel candidates. With a seasoned leadership team and strategic partnerships with entities like Eli Lilly and Boehringer Ingelheim, Centrexion is positioned to capitalize on growing governmental and private support for non-opioid analgesics and next-generation immunology medicines.
View full company profileTherapeutic Areas
Other Autoimmune/Inflammatory Diseases Drugs
| Drug | Company | Phase |
|---|---|---|
| Lead Program (Autoimmunity) | Immetas Therapeutics | Pre-clinical |
| Undisclosed Pipeline | IMMvention Therapeutix | Preclinical |